You are here

Sanofi to market new haemophilia drug in deal with Alnylam


FRENCH pharmaceutical group Sanofi said it has obtained the right to develop and sell a new haemophilia drug in a restructuring of its partnership with Alnylam Pharmaceuticals.

Under the agreement, Sanofi will obtain global development and commercialisation rights to...

Market voices on: